Skip to content
OpenHORIZON-HLTH-2027-01-DISEASE-10HaDEAOne-off

Prevention and management of chronic non-communicable diseases in children and young people (GACD)

Prevention and treatment of chronic diseases in children and young people (GACD).

Horizon Europe Research and Innovation Action (lump sum, approx. €3-4 million per project) for implementation research on the prevention and early diagnosis of chronic non-communicable diseases in children and young people, within the GACD.

Next deadline
91
days
17 February 2027
HORIZON-HLTH-2027-01-DISEASE-10
View all deadlines
Beta

This grant database is in beta

Until the official launch on 1 January 2027 we are making the final improvements. Our editors check every scheme, but details may still be incomplete or out of date. Check the official publication before you apply.

In brief

What is Prevention and management of chronic non-communicable diseases in children and young people (GACD)?

Who
A consortium of at least three independent organisations from three different countries, at least one of which is from an EU Member State and the others from Member States or Associated Countries; research organisations, companies of any size, public authorities, foundations and associations can take part. Organisations from the United States can also receive EU funding.
General Annex B (Entities eligible to participate; Entities eligible for funding; Consortium composition); Specific conditions, Eligibility conditions
What for
A Research and Innovation Action for implementation research on the prevention and treatment of chronic non-communicable diseases in children and young people, in order to prevent and detect these diseases more equitably and earlier.
Expected Outcome; Scope
What you get
A lump sum grant covering 100% of eligible costs; the Commission considers an EU contribution of €3 to 4 million per project appropriate. The indicative budget for the topic is €11.8 million, expected to fund 3 projects.
Specific conditions (Expected EU contribution per project, Indicative budget, Legal and financial set-up of the Grant Agreements); General Annex G, Funding rates
What you need to do
Submit a proposal in a single stage via the Funding & Tenders Portal between 29 October 2026 and 17 February 2027 (17:00 Brussels time) at the latest, with application form Part A and Part B, a detailed budget table for the lump sum and, if the proposal includes clinical studies, the annex on clinical studies. Independent experts evaluate and rank the proposals; results are expected around 5 months after the deadline.
Planned opening; Deadline(s); Application and evaluation forms; General Annex F

Built from the details on this page, with nothing added by us.

Purpose & impact

Why does this scheme exist?

Preventing and detecting chronic diseases in children and young people more equitably and earlier.

01
Evidence for early prevention
Researchers and healthcare providers in low- and middle-income countries, and in high-income countries serving disadvantaged groups, gain better insight into how to equitably promote early prevention, risk reduction and timely diagnosis of non-communicable diseases in children and young people.
02
Policy recommendations
Policymakers, public health services, parents, children and young adults have access to evidence and recommendations for national programmes and policies that improve the quality of life of children and young people and extend healthy life expectancy.
03
Scaling up interventions
Researchers, clinicians, policymakers and public health services have a better understanding of how to adapt and scale up interventions for the prevention and treatment of chronic diseases in children and young people at local, regional and national level.
04
Community engagement
Communities, parents, children, young adults, local stakeholders and governments are fully involved in the implementation of interventions against non-communicable diseases in children and young people.
Description

About the scheme

Compiled from passages of the scheme's official publication, with nothing added by us.

Chronic NCDs that begin in childhood have an impact on both quality of life and life expectancy. Onset of many NCDs diseases occurs at younger ages in LMICs, and this is further accompanied by a longer duration of disease and a higher rate of complications, including multimorbidity.

Read more

Childhood and adolescence are critical periods, when behaviours associated with NCD risk are adopted including tobacco use, alcohol use, substance abuse, unhealthy diets and sedentary lifestyles and children and young people are often targeted by commercial marketing of unhealthy products.

The aim of this topic is to fund implementation research, exploring strategies, evidence-based program and policy interventions across prevention, diagnosis, screening and management of chronic NCDs, centred on the critical life stages spanning early childhood to young adulthood (1-24 years of age) living in LMICs, and/or underserved populations in HICs.

Am I eligible?

Conditions

Quoted verbatim from the scheme, with the article that sets each condition.

01
To be eligible for funding, applicants must be established in one of the following countries:
02
Unless otherwise provided for in the specific call/topic conditions, only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows: – at least one independent legal entity established in a Member State; and – at least two other independent legal entities, each established in different Member States or Associated Countries.
03
Applications will only be considered eligible if their content corresponds, wholly or in part, to the topic description for which it is submitted.
04
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
05
If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).
All sizes
Micro< 10 FTE
Small< 50 FTE
Medium< 250 FTE
Large≥ 250 FTE
Themes
Onderzoek, ontwikkeling en innovatieGezondheid, zorg en welzijn
Project phase
ResearchDevelopment
Funding

What do you get?

100% of your eligible project costs.

Note on the maximum
No binding maximum; the Commission considers an EU contribution of €3 million to €4 million per project appropriate (lump sum).
€11.8m · Indicative topic budget, expected to fund 3 projects.
Budget status
Not published by the source
The sources do not say how much budget is left (checked 18 November 2026).
No double funding: an action may receive only one grant from the EU budget (except EU Synergy grants) and the same costs may never be declared under two different EU actions (General Annex G).
Type
Direct grant (non-repayable)
Calendar

Deadlines & cycles

17
FEB
HORIZON-HLTH-2027-01-DISEASE-10 closes 17 February 2027
Open since 29 October 2026
Planned opening; Deadline(s)Active
Cycle: Evaluation results around 5 months after the deadline; signature of the grant agreement around 8 months after the deadline (General Annex F). General Annex F, Indicative timetable for evaluation and for signature of the grant agreement
Application

How do you apply?

Pre-registration
Required, before the full application
Required attachments
  • Application form Part A: administrative details of the participants and summarised budget (to be completed online)
  • Application form Part B: technical description of the project (PDF, maximum 45 pages for a lump sum RIA)
  • Detailed budget table (HE LS) as the basis for the lump sum
  • Annex with information on clinical studies (HE template), if the proposal includes clinical studies
Procedure
Apply via the Funding & Tenders Portal with an EU Login and a PIC number; single-stage; deadline 17:00 Brussels time; managed by the European Health and Digital Executive Agency (HaDEA).
Eligible costs

What can the money be spent on?

Personnel costs
Not eligible
Materials
Not eligible
Subcontracting
Not eligible
Equipment
Not eligible
Land
Not eligible
Buildings
Not eligible
Overheads
Not eligible
Travel costs
Not eligible
Other costs
Lump sum: fixed contribution per work package, no cost reporting. Funding rate 100%.
Downloads

Files & forms

Changes

What has changed?

10 November 2026scheme · version 6

Subtitle
Subtitle: ChangedShow
Before

Preventie en behandeling van chronische ziekten bij kinderen en jongeren (GACD).

Now

Prevention and treatment of chronic diseases in children and young people (GACD).

Description
Description: ChangedShow
Before

Projecten doen implementatieonderzoek naar de vroege preventie, risicovermindering en tijdige diagnose van chronische niet-overdraagbare ziekten bij kinderen en jongeren in lage- en middeninkomenslanden of bij kwetsbare groepen in hoge-inkomenslanden, samen met de andere financiers van de Global Alliance for Chronic Diseases.

Now

Projects carry out implementation research on the early prevention, risk reduction and timely diagnosis of chronic non-communicable diseases in children and young people in low- and middle-income countries or among vulnerable groups in high-income countries, together with the other funders of the Global Alliance for Chronic Diseases.

Short description
Short description: ChangedShow
Before

Horizon Europe-onderzoeks- en innovatieactie (lump sum, circa € 3-4 mln per project) voor implementatieonderzoek naar preventie en vroege diagnose van chronische niet-overdraagbare ziekten bij kinderen en jongeren, binnen de GACD.

Now

Horizon Europe Research and Innovation Action (lump sum, approx. €3-4 million per project) for implementation research on the prevention and early diagnosis of chronic non-communicable diseases in children and young people, within the GACD.

Cycle
Cycle: ChangedShow
Before

Uitslag van de evaluatie rond 5 maanden na de deadline; ondertekening van de subsidieovereenkomst rond 8 maanden na de deadline (General Annex F).

Now

Evaluation results around 5 months after the deadline; signature of the grant agreement around 8 months after the deadline (General Annex F).

Note on the total budget
Note on the total budget: ChangedShow
Before

Indicatief topicbudget, naar verwachting 3 projecten.

Now

Indicative topic budget, expected to fund 3 projects.

Note on the maximum
Note on the maximum: ChangedShow
Before

Geen bindend maximum; de Commissie acht € 3 mln tot € 4 mln EU-bijdrage per project passend (lump sum).

Now

No binding maximum; the Commission considers an EU contribution of €3 million to €4 million per project appropriate (lump sum).

Cumulation
Cumulation: ChangedShow
Before

Geen dubbele financiering: een actie kan maar één subsidie uit de EU-begroting krijgen (behalve EU Synergy grants) en dezelfde kosten mogen nooit bij twee verschillende EU-acties worden gedeclareerd (General Annex G).

Now

No double funding: an action may receive only one grant from the EU budget (except EU Synergy grants) and the same costs may never be declared under two different EU actions (General Annex G).

Search engine title
Chronische ziekten bij kinderen en jongeren (GACD) becomes Chronic diseases in children and young people (GACD)
Search engine description
Search engine description: ChangedShow
Before

Horizon Europe-onderzoeksactie (lump sum, circa € 3-4 mln) voor preventie van chronische ziekten bij kinderen en jongeren (GACD).

Now

Horizon Europe research action (lump sum, approx. €3-4 million) for the prevention of chronic diseases in children and young people (GACD).

Keywords
chronische ziekten bij kinderen, Cluster 1 Health, Horizon Europe, HORIZON-HLTH-2027-01-DISEASE-10, lage- en middeninkomenslanden, preventie becomes chronic diseases in children, Cluster 1 Health, Horizon Europe, HORIZON-HLTH-2027-01-DISEASE-10, low- and middle-income countries, prevention
Language
Dutch (Netherlands) becomes British English
Required attachments
Aanvraagformulier deel A: administratieve gegevens van de deelnemers en samengevatte begroting (online in te vullen); Aanvraagformulier deel B: technische beschrijving van het project (pdf, maximaal 45 pagina's voor een lump-sum RIA); Gedetailleerde begrotingstabel (HE LS) als basis voor de lump sum; Bijlage met informatie over klinische studies (HE-sjabloon), als het voorstel klinische studies omvat becomes Application form Part A: administrative details of the participants and summarised budget (to be completed online); Application form Part B: technical description of the project (PDF, maximum 45 pages for a lump sum RIA); Detailed budget table (HE LS) as the basis for the lump sum; Annex with information on clinical studies (HE template), if the proposal includes clinical studies
Procedure
Procedure: ChangedShow
Before

Aanvragen via het Funding & Tenders Portal met een EU Login en een PIC-nummer; single-stage; deadline 17:00 uur Brusselse tijd; beheerd door European Health and Digital Executive Agency (HaDEA).

Now

Apply via the Funding & Tenders Portal with an EU Login and a PIC number; single-stage; deadline 17:00 Brussels time; managed by the European Health and Digital Executive Agency (HaDEA).

Notes per cost type
Notes per cost type: ChangedShow
Before

Other costs: Lump sum: vaste bijdrage per werkpakket, geen kostenverantwoording. Financieringspercentage 100%.

Now

Other costs: Lump sum: fixed contribution per work package, no cost reporting. Funding rate 100%.

Why this scheme
Why this scheme: ChangedShow
Before

Chronische ziekten bij kinderen en jongeren eerlijker en eerder voorkomen en opsporen.

Now

Preventing and detecting chronic diseases in children and young people more equitably and earlier.

In brief
In brief: ChangedShow
Before

Who: Een consortium van ten minste drie onafhankelijke organisaties uit drie verschillende landen, waarvan minstens één uit een EU-lidstaat en de andere uit lidstaten of geassocieerde landen; onderzoeksinstellingen, bedrijven van elke omvang, overheden, stichtingen en verenigingen kunnen deelnemen. Ook organisaties uit de Verenigde Staten kunnen EU-financiering krijgen.

What for: Een onderzoeks- en innovatieactie voor implementatieonderzoek naar preventie en behandeling van chronische niet-overdraagbare ziekten bij kinderen en jongeren, om die ziekten eerlijker en eerder te voorkomen en op te sporen.

What you get: Een lump-sum subsidie van 100% van de subsidiabele kosten; de Commissie acht een EU-bijdrage van € 3 tot 4 miljoen per project passend. Het indicatieve budget voor het topic is € 11,8 miljoen, naar verwachting voor 3 projecten.

What you need to do: Dien van 29 oktober 2026 tot uiterlijk 17 februari 2027 (17:00 uur Brusselse tijd) in één ronde een voorstel in via het Funding & Tenders Portal, met aanvraagformulier deel A en deel B, een gedetailleerde begrotingstabel voor de lump sum en, als het voorstel klinische studies omvat, de bijlage over klinische studies. Onafhankelijke experts beoordelen en rangschikken de voorstellen; de uitslag volgt naar verwachting circa 5 maanden na de deadline.

Now

Who: A consortium of at least three independent organisations from three different countries, at least one of which is from an EU Member State and the others from Member States or Associated Countries; research organisations, companies of any size, public authorities, foundations and associations can take part. Organisations from the United States can also receive EU funding.

What for: A Research and Innovation Action for implementation research on the prevention and treatment of chronic non-communicable diseases in children and young people, in order to prevent and detect these diseases more equitably and earlier.

What you get: A lump sum grant covering 100% of eligible costs; the Commission considers an EU contribution of €3 to 4 million per project appropriate. The indicative budget for the topic is €11.8 million, expected to fund 3 projects.

What you need to do: Submit a proposal in a single stage via the Funding & Tenders Portal between 29 October 2026 and 17 February 2027 (17:00 Brussels time) at the latest, with application form Part A and Part B, a detailed budget table for the lump sum and, if the proposal includes clinical studies, the annex on clinical studies. Independent experts evaluate and rank the proposals; results are expected around 5 months after the deadline.

Goals
Goals: 4 removed, 4 newShow
Removed

Bewijs voor vroege preventie Onderzoekers en zorgverleners in lage- en middeninkomenslanden, en in hoge-inkomenslanden die kansarme groepen bedienen, krijgen beter inzicht in hoe ze vroege preventie, risicoreductie en tijdige diagnose van niet-overdraagbare ziekten bij kinderen en jongeren rechtvaardig bevorderen.

Aanbevelingen voor beleid Beleidsmakers, publieke gezondheidsdiensten, ouders, kinderen en jongvolwassenen hebben toegang tot bewijs en aanbevelingen voor nationale programma's en beleid die de levenskwaliteit van kinderen en jongeren verbeteren en de gezonde levensverwachting verlengen.

Opschalen van interventies Onderzoekers, clinici, beleidsmakers en publieke gezondheidsdiensten weten beter hoe ze interventies voor preventie en behandeling van chronische ziekten bij kinderen en jongeren lokaal, regionaal en nationaal aanpassen en opschalen.

Betrokkenheid van gemeenschappen Gemeenschappen, ouders, kinderen, jongvolwassenen, lokale belanghebbenden en overheden zijn volledig betrokken bij de invoering van interventies tegen niet-overdraagbare ziekten bij kinderen en jongeren.

New

Evidence for early prevention Researchers and healthcare providers in low- and middle-income countries, and in high-income countries serving disadvantaged groups, gain better insight into how to equitably promote early prevention, risk reduction and timely diagnosis of non-communicable diseases in children and young people.

Policy recommendations Policymakers, public health services, parents, children and young adults have access to evidence and recommendations for national programmes and policies that improve the quality of life of children and young people and extend healthy life expectancy.

Scaling up interventions Researchers, clinicians, policymakers and public health services have a better understanding of how to adapt and scale up interventions for the prevention and treatment of chronic diseases in children and young people at local, regional and national level.

Community engagement Communities, parents, children, young adults, local stakeholders and governments are fully involved in the implementation of interventions against non-communicable diseases in children and young people.

Show 5 earlier versions

29 October 2026scheme · version 5

De call is op 29 oktober 2026 geopend. Voorstellen kunnen tot en met 17 februari 2027 worden ingediend.

Status
Opening soon becomes Open

19 October 2026scheme · version 4

Conditions
Conditions: 3 removed, 5 newShow
Removed

Consortium van minimaal 3 partijen Drie onafhankelijke juridische entiteiten uit drie verschillende EU-lidstaten of geassocieerde landen, waarvan minimaal één uit een lidstaat (General Annex B).

Ook Amerikaanse deelnemers financierbaar Juridische entiteiten uit de Verenigde Staten kunnen EU-financiering ontvangen (uitzondering op General Annex B).

GACD-implementatieonderzoek Het topic loopt gelijk met de twaalfde call van de Global Alliance for Chronic Diseases; projecten doen implementatieonderzoek met een gelijkwaardige samenwerking tussen hoge- en lage- of middeninkomenslanden.

New

To be eligible for funding, applicants must be established in one of the following countries:

Unless otherwise provided for in the specific call/topic conditions, only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows: – at least one independent legal entity established in a Member State; and – at least two other independent legal entities, each established in different Member States or Associated Countries.

Applications will only be considered eligible if their content corresponds, wholly or in part, to the topic description for which it is submitted.

In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.

If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).

In brief
In brief: AddedShow
Now

Who: Een consortium van ten minste drie onafhankelijke organisaties uit drie verschillende landen, waarvan minstens één uit een EU-lidstaat en de andere uit lidstaten of geassocieerde landen; onderzoeksinstellingen, bedrijven van elke omvang, overheden, stichtingen en verenigingen kunnen deelnemen. Ook organisaties uit de Verenigde Staten kunnen EU-financiering krijgen.

What for: Een onderzoeks- en innovatieactie voor implementatieonderzoek naar preventie en behandeling van chronische niet-overdraagbare ziekten bij kinderen en jongeren, om die ziekten eerlijker en eerder te voorkomen en op te sporen.

What you get: Een lump-sum subsidie van 100% van de subsidiabele kosten; de Commissie acht een EU-bijdrage van € 3 tot 4 miljoen per project passend. Het indicatieve budget voor het topic is € 11,8 miljoen, naar verwachting voor 3 projecten.

What you need to do: Dien van 29 oktober 2026 tot uiterlijk 17 februari 2027 (17:00 uur Brusselse tijd) in één ronde een voorstel in via het Funding & Tenders Portal, met aanvraagformulier deel A en deel B, een gedetailleerde begrotingstabel voor de lump sum en, als het voorstel klinische studies omvat, de bijlage over klinische studies. Onafhankelijke experts beoordelen en rangschikken de voorstellen; de uitslag volgt naar verwachting circa 5 maanden na de deadline.

18 October 2026scheme · version 3

About the scheme
About the scheme: AddedShow
Now

Chronic NCDs that begin in childhood have an impact on both quality of life and life expectancy. Onset of many NCDs diseases occurs at younger ages in LMICs, and this is further accompanied by a longer duration of disease and a higher rate of complications, including multimorbidity. Childhood and adolescence are critical periods, when behaviours associated with NCD risk are adopted including tobacco use, alcohol use, substance abuse, unhealthy diets and sedentary lifestyles and children and young people are often targeted by commercial marketing of unhealthy products. The aim of this topic is to fund implementation research, exploring strategies, evidence-based program and policy interventions across prevention, diagnosis, screening and management of chronic NCDs, centred on the critical life stages spanning early childhood to young adulthood (1-24 years of age) living in LMICs, and/or underserved populations in HICs.

16 October 2026scheme · version 2

Cycle
Cycle: AddedShow
Now

Uitslag van de evaluatie rond 5 maanden na de deadline; ondertekening van de subsidieovereenkomst rond 8 maanden na de deadline (General Annex F).

Cumulation
Cumulation: AddedShow
Now

Geen dubbele financiering: een actie kan maar één subsidie uit de EU-begroting krijgen (behalve EU Synergy grants) en dezelfde kosten mogen nooit bij twee verschillende EU-acties worden gedeclareerd (General Annex G).

Keywords
Added: chronische ziekten bij kinderen, Cluster 1 Health, Horizon Europe, HORIZON-HLTH-2027-01-DISEASE-10, lage- en middeninkomenslanden, preventie
Required attachments
Added: Aanvraagformulier deel A: administratieve gegevens van de deelnemers en samengevatte begroting (online in te vullen); Aanvraagformulier deel B: technische beschrijving van het project (pdf, maximaal 45 pagina's voor een lump-sum RIA); Gedetailleerde begrotingstabel (HE LS) als basis voor de lump sum; Bijlage met informatie over klinische studies (HE-sjabloon), als het voorstel klinische studies omvat
Goals
Goals: 4 newShow
New

Bewijs voor vroege preventie Onderzoekers en zorgverleners in lage- en middeninkomenslanden, en in hoge-inkomenslanden die kansarme groepen bedienen, krijgen beter inzicht in hoe ze vroege preventie, risicoreductie en tijdige diagnose van niet-overdraagbare ziekten bij kinderen en jongeren rechtvaardig bevorderen.

Aanbevelingen voor beleid Beleidsmakers, publieke gezondheidsdiensten, ouders, kinderen en jongvolwassenen hebben toegang tot bewijs en aanbevelingen voor nationale programma's en beleid die de levenskwaliteit van kinderen en jongeren verbeteren en de gezonde levensverwachting verlengen.

Opschalen van interventies Onderzoekers, clinici, beleidsmakers en publieke gezondheidsdiensten weten beter hoe ze interventies voor preventie en behandeling van chronische ziekten bij kinderen en jongeren lokaal, regionaal en nationaal aanpassen en opschalen.

Betrokkenheid van gemeenschappen Gemeenschappen, ouders, kinderen, jongvolwassenen, lokale belanghebbenden en overheden zijn volledig betrokken bij de invoering van interventies tegen niet-overdraagbare ziekten bij kinderen en jongeren.

7 October 2026scheme · version 1 · first publication

Source

Contact & source

Funding body
European Health and Digital Executive Agency
Last verified
18 November 2026 by the Twin editors
Start your application

Start your HORIZON-HLTH-2027-01-DISEASE-10 application
in Twin.

Twin helps you write your application, based on the scheme and your own project documents. You stay in control of every text.